Literature DB >> 11585449

Synthesis and biological evaluation of s-triazine substituted polyamines as potential new anti-trypanosomal drugs.

B Klenke1, M Stewart, M P Barrett, R Brun, I H Gilbert.   

Abstract

The P2 transporter is a nucleoside transporter which is unique to the protozoan parasite Trypanosoma brucei, the causative organism of Human African Trypanosomasis. The transporter has been shown to bind some structural motifs not recognized by other transporters. In this paper we describe the use of the melamine motif, a substrate of the P2 transporter, as a potential tool to selectively deliver polyamine analogues to the parasites. The synthesis of a number of polyamine analogues attached to a variety of melamine analogues is described. Many of the compounds were shown to competitively inhibit uptake of adenosine, indicating that they are recognized by the transporter. Some of the compounds showed good in vitro activity against the parasites.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585449     DOI: 10.1021/jm010854+

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  15 in total

1.  Gas phase reactions of 1,3,5-triazine: proton transfer, hydride transfer, and anionic σ-adduct formation.

Authors:  John M Garver; Zhibo Yang; Shuji Kato; Scott W Wren; Kristen M Vogelhuber; W Carl Lineberger; Veronica M Bierbaum
Journal:  J Am Soc Mass Spectrom       Date:  2011-04-19       Impact factor: 3.109

Review 2.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Interaction of monobenzamidine-linked trypanocides with the Trypanosoma brucei P2 aminopurine transporter.

Authors:  Mhairi L Stewart; Cyrille Boussard; Reto Brun; Ian H Gilbert; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

4.  Characterization of a melamino nitroheterocycle as a potential lead for the treatment of human african trypanosomiasis.

Authors:  Federica Giordani; Annamaria Buschini; Alessandro Baliani; Marcel Kaiser; Reto Brun; Michael P Barrett; Claudia Pellacani; Paola Poli; Ian H Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2014-07-14       Impact factor: 5.191

5.  Discovery of novel polyamine analogs with anti-protozoal activity by computer guided drug repositioning.

Authors:  Lucas N Alberca; María L Sbaraglini; Darío Balcazar; Laura Fraccaroli; Carolina Carrillo; Andrea Medeiros; Diego Benitez; Marcelo Comini; Alan Talevi
Journal:  J Comput Aided Mol Des       Date:  2016-02-18       Impact factor: 3.686

6.  Synthesis and anti-breast cancer activities of substituted quinolines.

Authors:  Aibin Shi; Thu A Nguyen; Srinivas K Battina; Sandeep Rana; Dolores J Takemoto; Peter K Chiang; Duy H Hua
Journal:  Bioorg Med Chem Lett       Date:  2008-04-13       Impact factor: 2.823

7.  Selective delivery of 2-hydroxy APA to Trypanosoma brucei using the melamine motif.

Authors:  Nina Klee; Pui Ee Wong; Beatriz Baragaña; Farah El Mazouni; Margaret A Phillips; Michael P Barrett; Ian H Gilbert
Journal:  Bioorg Med Chem Lett       Date:  2010-06-17       Impact factor: 2.823

8.  Trypanocidal activity of melamine-based nitroheterocycles.

Authors:  Mhairi L Stewart; Gorka Jimenez Bueno; Alessandro Baliani; Burkhard Klenke; Reto Brun; Janice M Brock; Ian H Gilbert; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Synthesis of 2,4,6-tri-substituted-1,3,5-triazines.

Authors:  Carlos A M Afonso; Nuno M T Lourenço; Andreia de A Rosatella
Journal:  Molecules       Date:  2006-01-31       Impact factor: 4.411

10.  Neglected disease - african sleeping sickness: recent synthetic and modeling advances.

Authors:  Sarvesh K Paliwal; Ankita Narayan Verma; Shailendra Paliwal
Journal:  Sci Pharm       Date:  2011-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.